Clinical Trial: A single-arm, multicenter, open-label, phase II clinical study of Vedotin for injection as second-line or later treatment for advanced biliary tract cancer (China)

China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A single-arm, multicenter, open-label, phase II clinical study of Vedotin for injection as second-line or later treatment for advanced biliary tract cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133501

Registration Time: 2026/09/28

Type: Interventional study

Primary Sponsor: Jiangmen Central Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345548

Published by HT Digital Content Services with permission from Health Daily Digest....